We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. If colchicine and its prospects as a COVID-19 treatment ...

Health insurance, The patient was treated at the hospital with the health of the insured. RECOVERY, a large, randomized clinical trial, assessed the efficacy of colchicine, a proposed treatment for ...

Depending on one’s perspective, the anti-inflammatory colchicine is either an unsung and underprescribed drug for patients with cardiovascular disease, or it’s an agent with limited clinical benefit ...

The media reports that colchicine, a very old drug, has now been discovered to reduce the risk of recurrent heart disease and has a new FDA indication. Of course, the “discovery” has taken 10 years, ...

Colchicine is one of the oldest medicines with potent anti-inflammatory functions, widely used to treat rheumatic diseases such as gout, calcium pyrophosphate deposition disease (CPDD), and familial ...

Please provide your email address to receive an email when new articles are posted on . In patients referred for PCI after acute heart attack, colchicine did not improve heart-related outcomes vs.

In a recent systematic review and meta-analysis published in PLOS ONE, researchers evaluated the use of colchicine in coronavirus disease 2019 (COVID-19) patients. Study: Safety and efficacy of ...

The recent US approval of a new low dose of colchicine 0.5 mg (Lodoco; Agepha Pharma) with a broad indication for use in atherosclerotic cardiovascular disease (ASCVD) represents a completely new ...

The Co-STAR trial tested the performance of colchicine in preventing new-onset arrhythmias and subclinical leaflet thrombosis after TAVR. The choice of periprocedural treatment with colchicine was ...

(RTTNews) - Scilex Holding Co. (SCLX) announced that FDA has approved it request for the Orphan drug designation for colchicine for the treatment of pericarditis. Pericarditis is an inflammation of ...